FADS2 induced the inflammatory response in the adipose tissue, which also supported the anti-inflammatory properties of nuciferine in NAFLD (Vaittinen et al., 2015). The gene discussed is FADS2; the disease is metabolic dysfunction-associated steatotic liver disease.